PF614

DRUG5 trials

Sponsors

Ensysce Biosciences

Conditions

Acute PainHealthyHealthy VolunteersRecreational Drug Use

Phase 1

Study of PF614 Compared to OxyContin® in Healthy Volunteers (PF614-101)

CompletedNCT02454712

Ensysce BiosciencesHealthy

Start: 2016-11-16End: 2018-01-18Updated: 2024-10-02

Evaluation of Oral PF614 Relative to OxyContin (PF614-102)

CompletedNCT05043766

Ensysce BiosciencesHealthy Volunteers

Start: 2021-09-08End: 2022-03-21Updated: 2024-09-24

A Study to Evaluate the Intranasal Abuse Potential of PF614 in Non-Dependent Recreational Opioid Users (PF614-103)

CompletedNCT05567354

Ensysce BiosciencesRecreational Drug Use

Start: 2022-06-10End: 2022-08-31Updated: 2024-09-24

A Study to Evaluate the Oral Abuse Potential of PF614 in Non-Dependent Recreational Opioid Users (PF614-104)

CompletedNCT05571345

Ensysce BiosciencesRecreational Drug Use

Start: 2022-10-05End: 2022-12-28Updated: 2024-09-24

Phase 2

Assessment of PF614 Effects on Experimental Pain in the Cold Pressure Test (PF614-201)

CompletedNCT06629402

Ensysce BiosciencesAcute Pain

Start: 2023-10-05End: 2023-11-15Updated: 2024-10-08